The Prescription Patterns and Clinical Efficacy of Tenero Tab/Tenero M SR Tab
Recruiting
- Conditions
- Diabetes Mellitus, Type 2
- Registration Number
- NCT06188234
- Lead Sponsor
- Hanlim Pharm. Co., Ltd.
- Brief Summary
This study is to observe the prescription patterns and clinical efficacy of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment in routine clinical practice.
- Detailed Description
This study is to observe the clinical efficacy by analyzing the prescription patterns in routine clinical practice and changes in HbA1c, FPG, PP2G, etc., of patients prescribed with Tenero Tab/Tenero M SR Tab for diabetes treatment. Additionally, the study intends to assess patient satisfaction based on these observations.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
- Adults over 19 years of age
- Individuals diagnosed with type 2 diabetes.
- Individuals who, at the clinical discretion, are prescribed Tenero Tab or Tenero M SR Tab for the purpose of diabetes treatment for the first time.
- Individuals who have voluntarily provided written consent to participate in this study.
Exclusion Criteria
- Pregnant or breastfeeding women.
- Individuals who are contraindicated according to the approved indications of Tenero Tab/Tenero M SR Tab.
- Other cases where the principal investigator and study personnel deem individuals ineligible for participation in this clinical trial.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline after 6 months of prescription for Tenero Tab/Tenero M SR Tab compared to baseline Change in HbA1c at 6 months of prescribing Tenero Tablet/Tenero Emextended Release Tablet compared to baseline
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cheonan Endo Medical Clinic
🇰🇷Cheonan, Korea, Republic of